Media Center
Press Releases

Press Releases

07 Apr 15
Diverse Pipeline Could Transform Liver Cancer Treatment within Next Decade

Liver cancer treatment has the potential to undergo an impressive transformation over the next 10 years, with a diverse pipeline of 218 products targeting several major needs that are unmet by the current market.

Read post
01 Apr 15
US Rheumatoid Arthritis Treatment Market Value to Reach $9.3 Billion by 2020, says GBI Research

The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%.

Read post
25 Mar 15
Antibiotics Pipeline Boasts 741 Products, but First-in-class Development Remains Low

While antibiotics boast a vast pipeline, with 741 products currently in development, the majority is dominated by generics, as weak financial incentives and high failure rates have discouraged innovation.

Read post
17 Mar 15
US Asthma Treatment Market Value to Hit $14 Billion by 2020, says GBI Research

The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 2.6%.

Read post
10 Mar 15
Big Pharma Drives Innovation in Pain Therapy Development, Despite Declining Patent Applications

Patent applications for novel pain therapeutics declined steadily in number from 4,970 in 2008 to 3,492 in 2012, an average annual decrease of 8%, as limited understanding of pain pathophysiology continues to hinder drug development in this arena.

Read post